DTRA seeks PR for new biothreat innovation prize
The announcement says that the open innovation challenge will be managed by DTRA's Chemical and Biological Technologies Department, according to GlobalBiodefense.com.
The U.S. Department of Defense hopes the call will lead to an enhancement of its capability to diagnose and treat biothreats to the U.S. Armed Forces that are brought on by a known, emerging or engineered pathogen. DTRA said that infectious diseases have a negative effect on military operations, including the impediment of combat effectiveness and the creation of a logistical burden.
"Because of the complexity of these problems, DTRA believes an open innovation development strategy is most likely to quickly yield a set of disruptive solutions to the threats posed by known, emerging, or engineered pathogens," the announcement says, GlobalBiodefense.com reports. "Specifically, the agency plans to pursue a strategy in which a large market stimulatory grand challenge is defined, developed, advertised, and administered including the award of a high value monetary prize to successful respondents."
DTRA said that a key element in its choice of sources will be the ability to perform public relations work with a large market and to conduct an intensive media campaign.